{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:29:47Z","timestamp":1790508587116,"version":"4.1.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>Cardiac allograft vasculopathy (CAV) is one of the leading causes of graft failure and death after heart transplantation. Alloimmune-dependent and -independent factors trigger the pathogenesis of CAV through activation of the recipients\u2019 (and to a lesser extent donor-derived) immune system. Early diagnosis of CAV is complicated by the lack of clinical symptoms for ischemia in the denervated heart, by the impact of early functional coronary alterations, by the insensitivity of coronary angiography, and by the involvement of small intramyocardial vessels. CAV in general is a panarterial disease confined to the allograft and characterized by diffuse concentric longitudinal intimal hyperplasia in the epicardial coronary arteries and concentric medial disease in the microvasculature. Plaque composition in CAV may include early fibrous and fibrofatty tissue and late atheromatous calcification. In contrast, native coronary atherosclerosis usually develops over decades, is focal, noncircumferential, and typically diminishes proximal parts of the epicardial vessels. The rapid and early development of CAV has an adverse prognostic impact, and current prevention and treatment strategies are of limited efficacy compared with established strategies in native atherosclerosis. Following acute coronary syndromes, patients after heart transplantation were more likely to have accompanying cardiogenic shock and higher mortality compared with acute coronary syndromes patients with native hearts.<\/jats:p>","DOI":"10.1097\/tp.0000000000004853","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:36Z","timestamp":1698624036000},"page":"1342-1349","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences"],"prefix":"10.1097","volume":"108","author":[{"given":"Michael","family":"Weis","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Krankenhaus Neuwittelsbach, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Weis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Krankenhaus Neuwittelsbach, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.107.711911","article-title":"Cardiac allograft vasculopathy: recent developments.","volume":"117","author":"Schmauss","year":"2008","journal-title":"Circulation"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/heartjnl-2020-318063","article-title":"Diagnosis and management of cardiac allograft vasculopathy.","volume":"108","author":"Ortega-Legaspi","year":"2022","journal-title":"Heart"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacc.2022.08.753","article-title":"The panvascular interplay in pathophysiology and prognosis of cardiac allograft vasculopathy.","volume":"80","author":"Mehra","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","article-title":"Allograft vasculopathy: the Achilles\u2019 heel of heart transplantation.","volume":"68","author":"Chih","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R5-20250604","first-page":"2624","article-title":"Cardiac allograft vasculopathy: current review and future research directions.","volume":"117","author":"Pober","year":"2021","journal-title":"Cardiovasc Res"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.RES.0000246086.93555.f3","article-title":"Allograft vasculopathy versus atherosclerosis.","volume":"99","author":"Rahmani","year":"2006","journal-title":"Circ Res"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-014-1586-6","article-title":"Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification.","volume":"464","author":"Angelini","year":"2014","journal-title":"Virchows Arch"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.amjcard.2016.01.036","article-title":"Comparison between cardiac allograft vasculopathy and native coronary atherosclerosis by optical coherence tomography.","volume":"117","author":"Shan","year":"2016","journal-title":"Am J Cardiol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/TP.0000000000001322","article-title":"Donor-transmitted atherosclerosis associated with worsening cardiac allograft vasculopathy after heart transplantation: serial volumetric intravascular ultrasound analysis.","volume":"101","author":"Watanabe","year":"2017","journal-title":"Transplantation"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1600-6143.2010.03401.x","article-title":"Early prediction of cardiac allograft vasculopathy and heart transplant failure.","volume":"11","author":"Labarrere","year":"2011","journal-title":"Am J Transplant"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12265-015-9612-x","article-title":"Cardiac allograft vasculopathy: a donor or recipient induced pathology?","volume":"8","author":"van den Hoogen","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.healun.2011.04.008","article-title":"Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.","volume":"30","author":"Lu","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1097\/TP.0000000000004101","article-title":"Finding the road to Rome in cardiac allograft vasculopathy imaging surveillance.","volume":"106","author":"Chih","year":"2022","journal-title":"Transplantation"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection.","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1053-2498(03)00222-5","article-title":"Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.","volume":"23","author":"Atkinson","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ehjci\/jev285","article-title":"Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis.","volume":"17","author":"Park","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.transproceed.2014.03.014","article-title":"Tissue characterization of progressive cardiac allograft vasculopathy in patients with everolimus therapy compared with donor-transmitted atherosclerosis assessed using serial intravascular imaging: a case report.","volume":"46","author":"Watanabe","year":"2014","journal-title":"Transplant Proc"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/TP.0000000000004395","article-title":"Change in first-year intravascular ultrasound results predicts adverse events in heart transplant recipients: implications for clinical trial endpoints.","volume":"107","author":"Seguchi","year":"2023","journal-title":"Transplantation"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"e008416","DOI":"10.1161\/CIRCHEARTFAILURE.121.008416","article-title":"Optical coherence tomography in cardiac allograft vasculopathy: state-of-the-art review.","volume":"14","author":"Acharya","year":"2021","journal-title":"Circ Heart Fail"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"e1266","DOI":"10.1097\/TXD.0000000000001266","article-title":"Analysis of fibrotic plaques in angiographic manifest cardiac allograft vasculopathy in long-term heart transplanted patients using optical coherence tomography.","volume":"8","author":"Orban","year":"2022","journal-title":"Transplant Direct"},{"key":"R21-20250604","first-page":"51","article-title":"Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.","volume":"17","author":"Ichibori","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0195-668X(03)00237-9","article-title":"Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.","volume":"24","author":"Vassalli","year":"2003","journal-title":"Eur Heart J"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"IX\/58","DOI":"10.1007\/s003920070030","article-title":"Heart allograft endothelial cell dysfunction Cause, course, and consequences.","volume":"89","author":"Weis","year":"2000","journal-title":"Z Kardiol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2005.10.073","article-title":"Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.","volume":"47","author":"Petrakopoulou","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/TP.0b013e318170b4cd","article-title":"Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation.","volume":"85","author":"Kubrich","year":"2008","journal-title":"Transplantation"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.healun.2008.01.001","article-title":"Graft-infiltrating dendritic cells and coronary endothelial dysfunction after human heart transplantation.","volume":"27","author":"Kofler","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.93.3.457","article-title":"Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant.","volume":"93","author":"Davis","year":"1996","journal-title":"Circulation"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.ATV.0000067060.31369.F9","article-title":"Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.","volume":"23","author":"Weis","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/oxfordjournals.eurheartj.a060419","article-title":"Endothelium-dependent and endothelium-independent vasomotion in large coronary arteries and in the microcirculation after cardiac transplantation.","volume":"15","author":"Hartmann","year":"1994","journal-title":"Eur Heart J"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.1997.03550140061041","article-title":"Endothelial activation and development of coronary artery disease in transplanted human hearts.","volume":"278","author":"Labarrere","year":"1997","journal-title":"JAMA"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1093\/eurheartj\/ehab568","article-title":"Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.","volume":"42","author":"Ahn","year":"2021","journal-title":"Eur Heart J"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCULATIONAHA.106.647149","article-title":"Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies.","volume":"116","author":"Hiemann","year":"2007","journal-title":"Circulation"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.CIR.0000109692.16004.AF","article-title":"Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.","volume":"109","author":"Weis","year":"2004","journal-title":"Circulation"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"II207","DOI":"10.1161\/01.CIR.0000138393.99310.1c","article-title":"Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.","volume":"110","author":"Petrakopoulou","year":"2004","journal-title":"Circulation"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2019.4748","article-title":"Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C.","volume":"5","author":"Schlendorf","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/23808993.2021.1840273","article-title":"The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care.","volume":"6","author":"Deng","year":"2021","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2020.07.010","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics.","volume":"39","author":"Khush","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.healun.2019.08.005","article-title":"Long-term outcome of cardiac allograft vasculopathy: importance of the International Society for Heart and Lung Transplantation angiographic grading scale.","volume":"38","author":"Van Keer","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcmg.2013.03.001","article-title":"Detection and imaging of cardiac allograft vasculopathy.","volume":"6","author":"Pollack","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"100569","DOI":"10.1016\/j.trre.2020.100569","article-title":"\u201cCardiac allograft vasculopathy: pathogenesis, diagnosis and therapy\u201d.","volume":"34","author":"Pighi","year":"2020","journal-title":"Transplant Rev (Orlando)"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/CIRCIMAGING.114.002184","article-title":"Prognostic value of rubidium-82 positron emission tomography in patients after heart transplant.","volume":"7","author":"Mc Ardle","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jacc.2018.01.063","article-title":"Functional and structural alterations in cardiac allograft vasculopathy.","volume":"71","author":"Weis","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamacardio.2017.2471","article-title":"Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve.","volume":"2","author":"Danad","year":"2017","journal-title":"JAMA Cardiol"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2018.01.062","article-title":"PET assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy.","volume":"71","author":"Chih","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s11886-022-01804-3","article-title":"PET myocardial blood flow for post-transplant surveillance and cardiac allograft vasculopathy in heart transplant recipients.","volume":"24","author":"Feher","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"e14124","DOI":"10.1111\/ctr.14124","article-title":"Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.","volume":"34","author":"Nelson","year":"2020","journal-title":"Clin Transplant"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.121.058459","article-title":"Computational analysis of routine biopsies improves diagnosis and prediction of cardiac allograft vasculopathy.","volume":"145","author":"Peyster","year":"2022","journal-title":"Circulation"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/TP.0000000000002704","article-title":"Cardiac allograft vasculopathy: the enduring enemy of cardiac transplantation.","volume":"103","author":"Nikolova","year":"2019","journal-title":"Transplantation"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.107.692996","article-title":"Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.","volume":"116","author":"Raichlin","year":"2007","journal-title":"Circulation"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pcad.2020.03.007","article-title":"Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy.","volume":"63","author":"Mallah","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0735-1097(01)01430-9","article-title":"Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation.","volume":"38","author":"Weis","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.tp.0000231505.91988.26","article-title":"Drugs modulating endothelial function after transplantation.","volume":"82","author":"Nickel","year":"2006","journal-title":"Transplantation"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.CIR.0000043241.32523.EE","article-title":"Simvastatin initiated early after heart transplantation: 8-year prospective experience.","volume":"107","author":"Wenke","year":"2003","journal-title":"Circulation"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.healun.2017.06.015","article-title":"Early aspirin use and the development of cardiac allograft vasculopathy.","volume":"36","author":"Kim","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.healun.2004.06.005","article-title":"The effect of combined angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.","volume":"24","author":"Erinc","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/01.TP.0000131148.78203.B7","article-title":"Beneficial effects of quinaprilat on coronary vasomotor function, endothelial oxidative stress, and endothelin activation after human heart transplantation.","volume":"77","author":"Steinhauff","year":"2004","journal-title":"Transplantation"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ccd.26830","article-title":"Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.","volume":"90","author":"Cheng","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ccd.22975","article-title":"Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature.","volume":"77","author":"Dasari","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tcm.2021.07.002","article-title":"Cardiac allograft vasculopathy after heart transplantation: pathophysiology, detection approaches, prevention, and treatment management.","volume":"32","author":"Spartalis","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2022.08.057","article-title":"Outcomes among heart transplant recipients following acute coronary syndrome: a nationwide population based study.","volume":"371","author":"Ram","year":"2023","journal-title":"Int J Cardiol"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/ajt.13418","article-title":"Retransplant and medical therapy for cardiac allograft vasculopathy: International Society for Heart and Lung Transplantation registry analysis.","volume":"16","author":"Goldraich","year":"2016","journal-title":"Am J Transplant"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult heart transplantation report-2018; focus theme: multiorgan transplantation.","volume":"37","author":"Khush","year":"2018","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:05:29Z","timestamp":1749045929000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004853","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}